[Lu-177]Lu-DOTA-TATE as First-line Therapy for Patients With Grade 2 and 3 Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): The NETTER-2 Study - Singh, Simron; Pavel, Marianne Ellen; Kunz, Pamela L.; De Herder, Wouter; Herrmann, Ken; D'Amelio, Anthony M.; Santoro, Paola; Folitar, Ilya; Ferone, Diego (PANCREAS, 2022)
CRIS-Team WoS Importer:2022-07-15